Polaris Partners VII, L.P., 10% Owner at Syros Pharmaceuticals, Inc. (SYRS), bought 1,964,486 shares at $12.50 ($10.0M) on 2016-07-06, disclosed to the SEC on 2016-07-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,164,486 | $0 | 0.0% |
| 2 | $12.50 | 26,153 | $327K | 3.3% |
| 3 | $12.50 | 26,153 | $327K | 3.3% |
| 4 | $12.50 | 373,847 | $4.7M | 46.7% |
| 5 | $12.50 | 373,847 | $4.7M | 46.7% |
| Total | $5.09 avg | 1,964,486 |
| $10.0M |
| 100% |
| Filing → |